Effects of Photobiomodulation on Postoperative Pain After Primary Endodontic Therapy in Molars With Symptomatic Apical Periodontitis
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the effects of photobiomodulation (PBM) on postoperative pain after endodontic treatment in mandibular molar teeth diagnosed with symptomatic apical periodontitis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: PBM Therapy
|
Device: PBM Therapy
After the endodontic treatment, PBM therapy will be performed using a 660 nm diode laser (SiroLaser Advance Plus, Dentsply Sirona Inc, Charlotte, NC, USA), with an 8mm tip diameter.The laser tip will be placed on the following external surfaces in a contact mode: mesiobuccal, distobuccal, mesiolingual and distolingual . The power output of the laser will be 50mW and will be verified by Power Meter (PM600 Power/Energy meter, Molectron Detector Inc, Portland, OR, USA). Each site will be irradiated for 25 s with an energy density of 10 J/cm2 .
|
Sham Comparator: PBM Sham
|
Device: PBM Sham
For the PBM sham similar procedure as PBM therapy will be performed without activating the laser.
|
Outcome Measures
Primary Outcome Measures
- Pain as assessed by the visual analog scale [72 hours after treatment]
This scale ranges form 0(no pain) to 10(worst pain)
Secondary Outcome Measures
- Change in pain as assessed by the visual analog scale [6 hours, 12 hours and 24 hours hours after treatment]
This scale ranges form 0(no pain) to 10(worst pain)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Posterior mandibular molars
-
No previous root canal therapy on the tooth in question
-
Able to complete the endodontic treatment in one visit
Exclusion Criteria:
-
Maxillary teeth, mandibular anteriors and premolars
-
Infection (swelling, sinus tract) on the tooth in question
-
Periodontal disease on the tooth in question
-
Dental trauma
-
Crown/ root fractures
-
Systemic diseases
-
Immunocompromised patients
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The University of Texas Health Science Center at Houston | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- The University of Texas Health Science Center, Houston
Investigators
- Principal Investigator: Ryne Jackson, DMD, The University of Texas Health Science Center, Houston
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HSC-DB-21-0579